相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of the ABCB11930_1931del TC Mutation in Two Suspected Ivermectin-Sensitive Cats and Their Relatives by a Novel TaqMan Allelic Discrimination Assay
Daniela Nuernberger et al.
FRONTIERS IN VETERINARY SCIENCE (2022)
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective
Kunal S. Taskar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs
Marlene Drag et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2022)
Role of an ABCB11930_1931del TC gene mutation in a temporal cluster of macrocyclic lactone-induced neurologic toxicosis in cats associated with products labeled for companion animal use
Katrina L. Mealey et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2021)
Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1-1Δ
Mark C. Heit et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2021)
Excessive Cyclosporine-Associated Immunosuppression in a Dog Heterozygous for the MDR1 (ABCB1-1Δ) Mutation
Andrew J. Mackin et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2020)
Personalized medicine: going to the dogs?
Katrina L. Mealey et al.
HUMAN GENETICS (2019)
Adverse Drug Reactions After Administration of Emodepside/Praziquantel (Profender®) in an MDR1-Mutant Australian Shepherd Dog: Case Report
Daniela Gaens et al.
FRONTIERS IN VETERINARY SCIENCE (2019)
Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis
Roberta Perego et al.
BMC VETERINARY RESEARCH (2019)
Drug-drug Interactions of P-gp Substrates Unrelated to CYP Metabolism
Yumiko Akamine et al.
CURRENT DRUG METABOLISM (2019)
Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
Rebecca E. Chandler
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid
Lujia Li et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Impact of ABCB1 genotype in Collies on the pharmacokinetics of R- and S-fexofenadine
Michael J. Myers et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2018)
Adverse reaction to apomorphine in a Collie homozygous for the ABCB1-1Δ (MDR1) mutation
Olivier Campbell et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2017)
Establishment of a cell line for assessing drugs as canine P-glycoprotein substrates: proof of principle
K. L. Mealey et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2017)
Loperamide-induced expression of immune and inflammatory genes in Collies associated with ivermectin sensitivity
M. Zhu et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2016)
The Effect of the Canine ABCB1-1 Mutation on Sedation after Intravenous Administration of Acepromazine
D. Deshpande et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2016)
Inhibition of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Regulates the Hepatobiliary Excretion and Plasma Exposure of Thienorphine and Its Glucuronide Conjugate
Ling-Lei Kong et al.
FRONTIERS IN PHARMACOLOGY (2016)
P-Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
K.L. Mealey et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Identification of a nonsense mutation in feline ABCB1
K. L. Mealey et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2015)
Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study
Michael J. Myers et al.
DRUG METABOLISM AND DISPOSITION (2015)
Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration
Feli M. Walther et al.
PARASITES & VECTORS (2014)
Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants
Yu-Jung Cha et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel
Jeroen J. M. A. Hendrikx et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
P-glycoprotein ABCB1: a major player in drug handling by mammals
Piet Borst et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
P-gp substrate-induced neurotoxicity in an Abcb1a knock-in/Abcb1b knock-out mouse model with a mutated canine ABCB1 targeted insertion
M. D. Swain et al.
RESEARCH IN VETERINARY SCIENCE (2013)
Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugs
Roger N. Gunn et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
Stewart T. Dunn et al.
DRUG METABOLISM AND DISPOSITION (2011)
Substrate- and Species-dependent Inhibition of P-glycoprotein-mediated Transport: Implications for Predicting in Vivo Drug Interactions
Joseph K. Zolnerciks et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation
Jeffrey G. Sherman et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2010)
Tissue Distribution of P-Glycoprotein in Cats
S. Van Der Heyden et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2009)
Ivermectin Toxicosis in Dogs: A Retrospective Study
Valentina Merola et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2009)
Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Δ mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency
J. C. Coelho et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
The Drug Transporter-Metabolism Alliance: Uncovering and Defining the Interplay
Leslie Z. Benet
MOLECULAR PHARMACEUTICS (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Stephen G. Aller et al.
SCIENCE (2009)
ABCB1-1Δ (MDR1-1Δ) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis
Joy L. Barbet et al.
VETERINARY DERMATOLOGY (2009)
In vitro drug-drug interaction screens for canine veterinary medicines: Evaluation of cytochrome P450 reversible inhibition
Divesh Aidasani et al.
DRUG METABOLISM AND DISPOSITION (2008)
P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine P-glycoprotein knockout model
Katrina L. Mealey et al.
DRUG METABOLISM AND DISPOSITION (2008)
Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies
Yoshiaki Kitamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
ABCB1-1Δ polymorphism can predict hematologic toxicity in dogs treated with vincristine
K. L. Mealey et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
The pharmacogenomics of P-glycoprotein and its role in veterinary medicine
M. Martinez et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2008)
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
S. -F. Zhou
XENOBIOTICA (2008)
Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions
R. Elsby et al.
XENOBIOTICA (2008)
In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system
Bo Feng et al.
DRUG METABOLISM AND DISPOSITION (2008)
Assessment of antiepileptic drugs as substrates fair canine P-glycoprotein
Chadwick L. West et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2007)
Concise review: Clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)
Serena Marchetti et al.
ONCOLOGIST (2007)
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction
D. Anglicheau et al.
KIDNEY INTERNATIONAL (2006)
Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein
J Griffin et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2005)
Treatment protocols for demodicosis: an evidence-based review
RS Mueller
VETERINARY DERMATOLOGY (2004)
Use of loperamide as a phenotypic probe of mdr1a status in CF-1 mice
JC Kalvass et al.
PHARMACEUTICAL RESEARCH (2004)
Importance of P-glycoprotein at blood-tissue barriers
MF Fromm
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Therapeutic implications of the MDR-1 gene
KL Mealey
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin
A Roulet et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
KL Mealey et al.
PHARMACOGENETICS (2001)
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel
MM Malingré et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1
S Conrad et al.
TOXICOLOGY (2001)
分享论文
